P975: interim analysis of phase ii study of daratumumab in combination with bortezomib and dexamethasone in patients with multiple myeloma who received 1 prior line of therapy (kmm1906)

K. H. Yoo, G. W. Gang, J. H. Yi, M. K. Kim,H. J. Kim,S.-H. Kim, J. S. Park,J.-J. Lee,C.-K. Min,J. H. Lee, D. Cho, K. Kim

HemaSphere(2022)

引用 0|浏览3
暂无评分
关键词
multiple myeloma,daratumumab,dexamethasone,bortezomib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要